Bandrés Gimeno Rafael, Muñoz Martínez María José
Servicio de Neumología, Hospital Xeral de Vigo, Complexo Hospitalario Universitario de Vigo, Vigo, Pontevedra, España.
Arch Bronconeumol. 2007 Jan;43(1):49-51.
Allergic bronchopulmonary aspergillosis is a lung disease characterized by an immune response to several antigens of Aspergillus species. Corticosteroids are the treatment of choice in the acute phase, although some studies have shown the efficacy of itraconazole. We describe the case of a favorable, prolonged therapeutic response to voriconazole in a patient with allergic bronchopulmonary aspergillosis who did not tolerate itraconazole.
变应性支气管肺曲霉菌病是一种肺部疾病,其特征为对曲霉菌属的几种抗原产生免疫反应。在急性期,皮质类固醇是首选治疗药物,尽管一些研究显示伊曲康唑也有疗效。我们描述了一例对伊曲康唑不耐受的变应性支气管肺曲霉菌病患者使用伏立康唑后获得良好且持久治疗反应的病例。